As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Call for papers: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum: 20 Years of Research Informing Practice
Addiction Science & Clinical Practice is pleased to announce an upcoming special series on the opioid use disorder (OUD) care continuum, specifically articles describing broad research and data supported by the National Drug Abuse Treatment Clinical Trials Network (CTN): its past effort in developing MOUD treatment and current effort in improving MOUD treatment quality.
Edited by E. Jennifer Edelman and Andrew J. Saxon, the series will commemorate 20 years of CTN research activities.
Addiction Science & Clinical Practice is pleased to present our special series focusing on digital/information technology (IT) screening and interventions to advance treatment for opioid and other substance use disorders.
Edited by Nicolas Bertholet and John Cunningham, the series highlights in an open-access format articles that address the use of information technology in the prevention and clinical care of people suffering from addiction and in the training and clinical support of health care providers treating addiction.
We are pleased to announce an upcoming cross-journal series to focus on tobacco and alcohol policy.
This special thematic series aims to bring together a selection of the latest research and developments surrounding global alcohol and tobacco policy, from a variety of different viewpoints.
Goa, India will host the International Network on Brief Interventions for Alcohol & Other Drugs 17th Annual Conference, running 23-25 September 2020.
This year's theme is "Setting new directions for brief interventions".
Visit the INEBRIA website for more information.
Addiction Science & Clinical Practice is pleased to publish our special series of research studies on addiction treatment access and utilization among criminal justice involved populations.
Edited by Andrea Finlay, Ingrid Binswanger, and Christine Timko, the series aims to advance understanding of how to improve health outcomes among criminal justice populations who have substance use disorders or use substances in the U.S. and international settings.
We are pleased to announce that Addiction Science & Clinical Practice has recently been accepted to be indexed in Clarivate Analytics' Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). The journal is expected to receive its first impact factor in 2020.
ASCP articles are currently also included in Scopus, PubMed, PubMed Central, MEDLINE and DOAJ.
Aims and scope
Addiction Science & Clinical Practice provides a forum for clinically relevant research and perspectives that contribute to improving the quality of care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviours across a spectrum of clinical settings.
Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.
Latest NIDA news
Failed to load RSS feed.
Dr Jeffrey Samet, Editor-in-Chief
"Improving the quality of care provided to patients with problems from the use of alcohol and other drugs should be a major health-care goal and research agenda as articulated in the 2006 US Institute of Medicine report, Improving the Quality of Health Care for Mental and Substance Use Conditions. Our goal is to make Addiction Science & Clinical Practice the primary home for evidence to address this international health-care challenge."
International Network on Brief Interventions for Alcohol & Other Drugs
INEBRIA is an international network of researchers, policy makers, practitioners and other stakeholders interested in the potential of brief interventions in health and other settings to reduce the harms produced by alcohol and other drug use. Its main goals are:
1. To share information, experiences, research findings and expertise in the area of early identification and brief intervention for hazardous and harmful substance use.
2. To promote best practice in, and encourage the development of, guidelines for the wide dissemination and implementation of evidence-based early identification and brief intervention for hazardous and harmful substance use.
3. To identify gaps and needs for research in the field of early identification and brief intervention for hazardous and harmful substance use, promote International research co-operation and set standards for research.
4. To Promote the Integration of the study of brief interventions for hazardous and harmful substance use with the wider context of measures to prevent and reduce substance-related harm.
Addiction Science & Clinical Practice is affiliated with the International Network on Brief Interventions for Alcohol & Other Drugs.